Table 1 Characteristics of the study participants

From: Risk of prostate cancer in a population-based cohort of men with coeliac disease

 

Matched controls

Patients with CD

Total

54 233

10 995

Age and follow-up

 Age at study entry, years (median, range)

34; 0–95

35; 0–95

 Age 0–19 (%)

21 734 (40.1)

4356 (39.6)

 Age 20–39 (%)

8216 (15.1)

1659 (15.1)

 Age 40–59 (%)

12 946 (23.9)

2605 (23.7)

 Age 60 (%)

11 337 (20.9)

2375 (21.6)

 Entry year (median, range)

1998; 1969–2007

1998; 1969–2007

 Follow-up, years (median, range)a

8; 0–39

8; 0–37

 Follow-up, years (mean±SD)a

9.5±6.4

9.3±6.4

Calendar year

 -1989 (%)

8101 (14.9)

1643 (14.9)

 1990–1999 (%)

22 824 (42.1)

4627 (42.1)

 2000- (%)

23 308 (43.0)

4725 (43.0)

Covariates

 Nordic country of birth (%)b

51 241 (94.5)

10 662 (97.0)

 Type 1 diabetes (%)

208 (0.4)

418 (3.8)

  1. Abbreviation: CD=coeliac disease.
  2. a Follow-up time until diagnosis of prostate, death from other cause, emigration, or 31 December 2007. In reference individuals, follow-up could end if the patients underwent a small intestinal biopsy.
  3. b Sweden, Denmark. Finland, Norway, and Iceland.